Department of Neurology

A sensorimotor enhanced neuromusculoskeletal model for simulating postural control of upright standing (2024) Shanbhag J, Fleischmann S, Wechsler I, Gaßner H, Winkler J, Eskofier B, Koelewijn A, et al. Journal article Effects of physiotherapy and home-based training in parkinsonian syndromes: protocol for a randomised controlled trial (MobilityAPP) (2024) Raccagni C, Sidoroff V, Paraschiv-Ionescu A, Roth N, Schönherr G, Eskofier B, Gaßner H, et al. Journal article A New Immortalized Human Lacrimal Gland Cell Line (2024) Gleixner S, Zahn I, Dietrich J, Singh S, Drobny A, Schneider Y, Schwendner R, et al. Journal article CSF1R-mediated myeloid cell depletion shifts the ratio of motor cortical excitatory to inhibitory neurons in a multiple system atrophy model (2024) Gauer C, Battis K, Schneider Y, Florio JB, Mante M, Kim HY, Rissman RA, et al. Journal article Unraveling the complexity of alpha-synucleinopathies: Insights from the special issue “alpha synuclein and synucleinopathies” (2024) Xiang W, Vicente Miranda H Journal article Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances (2024) Moceri S, Bäuerle N, Habermeyer J, Ratz-Wirsching V, Harrer J, Distler J, Schulze-Krebs A, et al. Journal article Expression of Inflammatory Mediators in Biofilm Samples and Clinical Association in Multiple Sclerosis Patients in Remission—A Pilot Study (2024) Fehlhofer JP, Ries J, Nickel F, Rothhammer V, Schwab S, Kesting MR, Buchbender M Journal article Gut–Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond (2024) Zißler J, Rothhammer V, Linnerbauer M Journal article, Review article Successful Pharmacologic Treatment of Self-Bloodletting with Factitious Chronic Anemia (Lasthénie de Ferjol Syndrome) with High-Dose Serotonergic Medication: A Case Report (2024) Mestermann S, Rudtke L, Brazdis RM, Tsaktanis T, Kornhuber J, Thürauf N Journal article Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program (2024) Wiesenfarth M, Dorst J, Brenner D, Elmas Z, Parlak Ö, Uzelac Z, Kandler K, et al. Journal article